TY - JOUR
T1 - Association of Mal/TIRAP S180L variant polymorphism with decreased infection risk in patients with advanced HIV-1 infection
AU - Papadopoulos, Antonios I.
AU - Ferwerda, Bart
AU - Antoniadou, Anastasia
AU - Sakka, Vissaria
AU - Galani, Lambrini
AU - Kavatha, Dimitra
AU - Panagopoulos, Periklis
AU - Poulakou, Garyphalia
AU - Protopapas, Konstantinos
AU - van der Meer, Jos W.M.
AU - Netea, Mihai G.
AU - Giamarellos-Bourboulis, Evangelos J.
N1 - Funding Information: M.G.N. was supported by a Vici Grant of the Netherlands Organization of Scientific Research.
PY - 2012/10
Y1 - 2012/10
N2 - Objectives: MyD88 adaptor-like (Mal/TIRAP) is an adaptor protein bridging activation of Toll-like receptors 2 and 4 after stimulation by exogenous and endogenous ligands. We investigated the association between the presence of the S180L SNP of Mal and the risk of severe infection in individuals with human immunodeficiency virus (HIV)-1 infection. Methods: The SNP S180L was determined in a cohort of 179 HIV-1 infected Greek patients. Analysis of the prevalence of this SNP in relation to the infectious complications was evaluated. Results: One hundred and thirty-two (73.3%) patients were bearing the wild type haplotype, 43 (24%) were heterozygous for the SNP, and four (2.2%) were homozygous for the variant allele. The individuals with a nadir CD4 count <200cells/mm3 who carried the 180L variant demonstrated a 4-fold decrease in the odds ratio (OR) for any serious infection compared with those who carried the wild-type 180S genotype (OR 0.58 vs OR 2.6, p=0.016). Conclusions: This study suggest a protection effect of the Mal S180L SNP against serious infections in HIV-1 infected individuals with low CD4 cell counts.
AB - Objectives: MyD88 adaptor-like (Mal/TIRAP) is an adaptor protein bridging activation of Toll-like receptors 2 and 4 after stimulation by exogenous and endogenous ligands. We investigated the association between the presence of the S180L SNP of Mal and the risk of severe infection in individuals with human immunodeficiency virus (HIV)-1 infection. Methods: The SNP S180L was determined in a cohort of 179 HIV-1 infected Greek patients. Analysis of the prevalence of this SNP in relation to the infectious complications was evaluated. Results: One hundred and thirty-two (73.3%) patients were bearing the wild type haplotype, 43 (24%) were heterozygous for the SNP, and four (2.2%) were homozygous for the variant allele. The individuals with a nadir CD4 count <200cells/mm3 who carried the 180L variant demonstrated a 4-fold decrease in the odds ratio (OR) for any serious infection compared with those who carried the wild-type 180S genotype (OR 0.58 vs OR 2.6, p=0.016). Conclusions: This study suggest a protection effect of the Mal S180L SNP against serious infections in HIV-1 infected individuals with low CD4 cell counts.
KW - Adapter proteins
KW - HIV infection
KW - Infection risk
KW - Mal polymorphisms
UR - http://www.scopus.com/inward/record.url?scp=84865410348&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.cyto.2012.05.008
DO - https://doi.org/10.1016/j.cyto.2012.05.008
M3 - Article
C2 - 22683004
SN - 1043-4666
VL - 60
SP - 104
EP - 107
JO - Cytokine
JF - Cytokine
IS - 1
ER -